These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30447715)

  • 1. Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
    Heitner SB; Fischer KL
    Cardiol Clin; 2019 Feb; 37(1):45-54. PubMed ID: 30447715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Pharmacotherapy for Hypertrophic Cardiomyopathy.
    Wong TC; Martinez M
    Cardiol Clin; 2019 Feb; 37(1):113-117. PubMed ID: 30447712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy.
    Louie EK; Edwards LC
    Prog Cardiovasc Dis; 1994; 36(4):275-308. PubMed ID: 7904358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertrophic obstructive cardiomyopathy: current treatment, indications and results].
    Delahaye JP; Azzano O
    Presse Med; 1994 May; 23(20):925-7. PubMed ID: 7937627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil.
    Sherrid MV; Shetty A; Winson G; Kim B; Musat D; Alviar CL; Homel P; Balaram SK; Swistel DG
    Circ Heart Fail; 2013 Jul; 6(4):694-702. PubMed ID: 23704138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical and surgical therapy of hypertrophic cardiomyopathy.
    Bonow RO; Maron BJ; Leon MB; Cannon RO; Epstein SE
    Cardiovasc Clin; 1988; 19(1):221-39. PubMed ID: 2901911
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy.
    Blanchard DG; Ross J
    Clin Cardiol; 1991 Jan; 14(1):11-9. PubMed ID: 1673364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in medical treatment of hypertrophic cardiomyopathy.
    Hamada M; Ikeda S; Shigematsu Y
    J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy.
    Yoerger DM; Weyman AE
    Rev Cardiovasc Med; 2003; 4(4):199-215. PubMed ID: 14668688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.
    Andries G; Yandrapalli S; Naidu SS; Panza JA
    Cardiol Rev; 2018; 26(5):239-244. PubMed ID: 29746257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment.
    Musat D; Sherrid MV
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():9-17. PubMed ID: 17162264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Nishimura RA
    Circ Cardiovasc Interv; 2013 Oct; 6(5):586-91. PubMed ID: 24129935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment for cardiomyopathies].
    Suwa M
    Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program.
    Rothman RD; Baggish AL; O'Callaghan C; Lowry PA; Bhatt AB; MacRae CA; Yannekis G; Sanborn DM; Mela T; Yeh RW; Palacios I; Vlahakes GJ; Fifer MA
    Am J Cardiol; 2012 Oct; 110(8):1169-74. PubMed ID: 22766229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of arrhythmia in hypertrophic cardiomyopathy].
    Lengfelder W; Senges J
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1359-61. PubMed ID: 1679389
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: investigational drugs inhibiting myosin and upcoming agents.
    Hajj Ali A; Mehra N; Desai MY
    Expert Opin Investig Drugs; 2023; 32(9):849-853. PubMed ID: 37787068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hypertropic obstructive cardiomyopathy].
    Gleichmann U; Seggewiss H
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1485-6. PubMed ID: 8983903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.